Chemical Structure (Atzumi 01)
Atzumi Powder
Product Images NDC 76978-101
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Atzumi (NDC 76978-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Satsuma Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Atzumi 02)
This text provides information on the estimated probability of response to study medication (Dihydroergotamine Mesylate) over time in Studies 1 and 2. The data includes the number of participants in each group (208 for Dihydroergotamine Mesylate and 200 for Placebo) and the time from the first dose in hours for analysis.*
Figure (Atzumi 03)
This text provides information on the percentage of response to study medication in Studies 3 and 4, comparing Dihydroergotamine Mesylate to Placebo. The data is presented over a period of time from the first dose in hours (1, 2, 3, and 4 hours).*
Figure (Atzumi 04)
This text provides data from a clinical study comparing Dihydroergotamine Mesylate with a Placebo, where the efficacy is measured over time (0, 4, 8, 12 hours after the first spray). The study involved a sample size of 305 for Dihydroergotamine Mesylate and 300 for Placebo.*
Image (Atzumi 05)
This description is not available.*
Image (Atzumi 06)
This is a Protective Foil Pouch designed to keep items safe from environmental factors. The pouch features tear notches on the front and back for easy opening. It also includes space to write the expiration date of the contents. Ideal for storing small items or products that need protection.*
Image (Atzumi 07)
Store in protective foil pouch until ready to use.*
Image (Atzumi 08)
Image (Atzumi 09)
Image (Atzumi 10)
Image (Atzumi 11)
Image (Atzumi 12)
Image (Atzumi 13)
Image (Atzumi 14)
This text provides instructions for using a white air pump to clear a nostril. It suggests squeezing the pump three times into one nostril while inhaling through the nose. It also includes guidance on the timing for each squeeze and the associated inhalation, followed by release.*
Image (Atzumi 15)
Image (Atzumi 16)
This text provides instructions on how to administer the remaining loose powdered medicine into the same nostril.*
Image (Atzumi 17)
Image (Atzumi 18)
Image (Atzumi 19)
Image (Atzumi 20)
This text is not available.*
Image (Atzumi 21)
Principal Display Panel (5.2 mg Bottle Carton)
Principal Display Panel (5.2 mg Device Pouch Label)
This is important information about a medication called Atzumi (dihydroergotamine) nasal powder with a strength of 5.2mg. It is intended for nasal use only and should be discarded after use. The package contains 1 prefilled single-dose device and the storage instructions are to keep it in its protective pouch at room temperature. The text provides clear instructions on how to use Atzumi, including steps such as blowing your nose, inserting the nozzle into your nostril, and squeezing the air pump to deliver the powdered medicine. The Quick Reference Guide is included with details on how to properly use the device and discard it after use.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
